RSS Feeds
Search

Deals review

GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Related deals

Novavax and Xcellerex Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine

Cellexus Limited and Groton Biosystems Collaborate on Use of Automated Sampling With Single-Use Bioreactors for Aseptic Sample Extraction from Cell Culture

Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform

Juvaris BioTherapeutics Announces Collaboration with the International AIDS Vaccine Initiative

Sartorius secures key technology for disposable bioreactors

ProBioGen and Saxonia BioTec collaborate: New types of bioreactors for research and diagnostics.

Sartorius AG and Wave Biotech AG, Switzerland, agreed on forming a strategic alliance to jointly develop the market for disposable bioreactors

Juvaris BioTherapeutics Announces Collaboration with Penn State University for Acute Myelogenous Leukmia

GTC BIOTHERAPEUTICS AND PHARMATHENE EXTEND AGREEMENT FOR PROTEXIA® PROGRAM

FIND and the Government of Lesotho sign an agreement for an effective response to XDR-TB in the southern African region

More deals

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us